ALVESCO Side Effects

7026600-0 | Acidosis, Brain Natriuretic Peptide Increased, Cardiac Failure Congestive, Respiratory Failure, Status Asthmaticus
on Sep 16, 2010 Male patient from GERMANY , 82 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: acidosis, brain natriuretic peptide increased, cardiac failure congestive, respiratory failure, status asthmaticus. Alvesco dosage: 200 Ug;qd;inhalation. During the same period patient was treated with MUCOSOLVAN /00546001/ (View Mucosolvan /00546001/ Review and Mucosolvan /00546001/ Label ), MUCOTRON (View Mucotron Review and Mucotron Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

7001635-2 | Aortic Aneurysm, Breast Cancer, Contusion, Ear Infection, Excoriation
Patient was taking Alvesco (View Usage). Patient had the following side effects: aortic aneurysm (What is aortic aneurysm?), breast cancer (What is breast cancer?), contusion, ear infection (What is ear infection?), excoriation on Sep 02, 2010 from Additional patient health information: Female patient , 71 years of age, was diagnosed with chronic obstructive pulmonary disease and. Alvesco dosage: 160 Ug; Qd; Inhalation. During the same period patient was treated with SPIRIVA (View Spiriva Review and Spiriva Label ), CALCIUM CHANNEL (View Calcium Channel Review and Calcium Channel Label ), BLOCKERS (View Blockers Review and Blockers Label ), PROVENTIL HFA /00139501/ (View Proventil Hfa /00139501/ Review and Proventil Hfa /00139501/ Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ).

6936966-5 | Asthma, Myocardial Infarction, No Therapeutic Response, Stress Cardiomyopathy, Wheezing
Adverse event was reported on Aug 04, 2010 by a Female patient taking Alvesco (View Usage) (Dosage: 200 Ug; Bid; Inhalation, 400 Ug; Bid; Inhalation) was diagnosed with asthma (What is asthma?), musculoskeletal stiffness, pancreatitis chronic, constipation (What is constipation?), iron deficiency anaemia, chloasma, gastritis and. Location: JAPAN , 83 years of age, After Alvesco was administered, patient had the following side effects: asthma (What is asthma?), myocardial infarction, no therapeutic response, stress cardiomyopathy, wheezing. During the same period patient was treated with KAKKON TO (KAKKON TO) (7.5 Gm; ; Oral) (View Kakkon-to (kakkon-to) Review and Kakkon-to (kakkon-to) Label ), CAMOSTAT (CAMOSTAT) (300 Mg; ; Oral) (View Camostat (camostat) Review and Camostat (camostat) Label ), MAGMITT (MAGNESIUM OXIDE) (990 Mg; ; Oral) (View Magmitt (magnesium Oxide) Review and Magmitt (magnesium Oxide) Label ), DEXTROMETHORPHAN HYDROBROMIDE (90 Mg; ; Oral) (View Dextromethorphan Hydrobromide Review and Dextromethorphan Hydrobromide Label ), FERROMIA /00023516/ (FERROUS CITRATE) (100 Mg; ; Oral) (View Ferromia /00023516/ (ferrous Citrate) Review and Ferromia /00023516/ (ferrous Citrate) Label ), CINAL /00257901/ (CINAL /00257901/) (1 Gm; ; Oral) (View Cinal /00257901/ (cinal /00257901/) Review and Cinal /00257901/ (cinal /00257901/) Label ), SELBEX (TEPRENONE) (0.5 Gm; ; Oral) (View Selbex (teprenone) Review and Selbex (teprenone) Label ). Patient was hospitalized.

6925062-9 | Arthralgia, Gait Disturbance, Joint Instability, Joint Stiffness, Joint Swelling, Musculoskeletal Discomfort
on Jul 27, 2010 Male patient from UNITED STATES , child 11 years of age, weighting 80.91 lb, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, gait disturbance, joint instability, joint stiffness, joint swelling, musculoskeletal discomfort. Alvesco dosage: 160 Ug;bid;inhalation. During the same period patient was treated with PREVACID (View Prevacid Review and Prevacid Label ).


6917558-0 | Dyspnoea, Feeling Abnormal, Speech Disorder, Throat Tightness
on Jul 26, 2010 Female patient from GERMANY , 37 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient had the following side effects: dyspnoea, feeling abnormal, speech disorder, throat tightness. Alvesco dosage: 600 Ug; Bid; Inhalation. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ). Patient was hospitalized.

6916271-3 | Anaphylactic Reaction, Anxiety, Respiratory Disorder
Patient was taking Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: anaphylactic reaction, anxiety (What is anxiety?), respiratory disorder on Jul 21, 2010 from GERMANY Additional patient health information: Male patient , 25 years of age, was diagnosed with asthma (What is asthma?) and. Alvesco dosage: 160 Ug; 1x; Inhalation. During the same period patient was treated with BUDESONIDE (View Budesonide Review and Budesonide Label ).

6900595-X | Bronchospasm, Rash
Adverse event was reported on Jul 19, 2010 by a Male patient taking Alvesco (View Usage) (Dosage: Qd Inhalation) was diagnosed with asthma (What is asthma?) and. Location: GERMANY , 14 years of age, weighting 108.0 lb, Patient experienced the following unwanted or unexpected effects: bronchospasm, rash (What is rash?).

6884973-3 | Concussion, Contusion, Dizziness, Loss Of Consciousness, Road Traffic Accident, Wound
on Jul 12, 2010 Female patient from UNITED STATES , 89 years of age, weighting 140.0 lb, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient had the following side effects: concussion (What is concussion?), contusion, dizziness (What is dizziness?), loss of consciousness, road traffic accident, wound (What is wound?). Alvesco dosage: Qd; Inhalation. During the same period patient was treated with EYE DROPS (View Eye Drops Review and Eye Drops Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), VITAMIN TAB (View Vitamin Tab Review and Vitamin Tab Label ), GINKGO BILOBA (View Ginkgo Biloba Review and Ginkgo Biloba Label ).

6865816-0 | Bronchospasm, Rash
on Jun 08, 2010 Male patient from GERMANY , 14 years of age, weighting 108.0 lb, was treated with Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: bronchospasm, rash (What is rash?). Alvesco dosage: Qd; Inhalation.

6846969-7 | Dyspnoea, Feeling Abnormal
Patient was taking Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, feeling abnormal on Jun 30, 2010 from GERMANY Additional patient health information: Female patient , 37 years of age, was diagnosed with asthma (What is asthma?) and. Alvesco dosage: 200 Ug;bid;inhalation. During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), THEO DUR (View Theo-dur Review and Theo-dur Label ), MEPTIN (View Meptin Review and Meptin Label ). Patient was hospitalized.

6836298-X | Arthralgia, Arthropathy, Fall, Gait Disturbance, Joint Stiffness
Adverse event was reported on Jul 12, 2010 by a Male patient taking Alvesco (View Usage) (Dosage: 2 Puffs Bid Po) was diagnosed with asthma (What is asthma?) and. Location: UNITED STATES , child 11 years of age, weighting 82.00 lb, Patient had the following side effects: arthralgia, arthropathy, fall (What is fall?), gait disturbance, joint stiffness.

6817114-9 | Rash
on Jun 16, 2010 Female patient from GERMANY , 45 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: rash (What is rash?). Alvesco dosage: 320 Ug; Qd; Inhalation. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), SERETIDE /01420901/ (SERETIDE /01420901/) (View Seretide /01420901/ (seretide /01420901/) Review and Seretide /01420901/ (seretide /01420901/) Label ).

6782204-6 | Dyspnoea, Eczema, Lip Swelling, Oral Candidiasis, Rash, Skin Disorder, Urticaria
on Jun 04, 2010 Female patient from GERMANY , 90 years of age, was diagnosed with lower respiratory tract infection and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, eczema (What is eczema?), lip swelling, oral candidiasis, rash (What is rash?), skin disorder, urticaria. Alvesco dosage: 160 Ug; Qd; Inhalation. During the same period patient was treated with CEFACLOR (View Cefaclor Review and Cefaclor Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), SEREVENT (View Serevent Review and Serevent Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), LORATADINE (View Loratadine Review and Loratadine Label ), EYE DROPS (View Eye Drops Review and Eye Drops Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6766593-4 | Electrocardiogram Qt Prolonged
Patient was taking Alvesco (View Usage). Patient had the following side effects: electrocardiogram qt prolonged on May 25, 2010 from GERMANY Additional patient health information: Male patient , child 2 years of age, . Alvesco dosage: Inhalation.

6755556-0 | Dyspnoea, Eczema, Oral Candidiasis, Rash, Urticaria
Adverse event was reported on May 20, 2010 by a Female patient taking Alvesco (View Usage) (Dosage: 160 Ug; Qd; Inhalation) was diagnosed with lower respiratory tract infection and. Location: GERMANY , 90 years of age, After Alvesco was administered, patient had the following side effects: dyspnoea, eczema (What is eczema?), oral candidiasis, rash (What is rash?), urticaria. During the same period patient was treated with CEFACLOR (View Cefaclor Review and Cefaclor Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), SEREVENT (View Serevent Review and Serevent Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), LORATADINE (View Loratadine Review and Loratadine Label ), EYE DROPS (View Eye Drops Review and Eye Drops Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

6750369-8 | Aortic Thrombosis, Dyspnoea, Fatigue
on May 13, 2010 Male patient from UNITED STATES , 78 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: aortic thrombosis, dyspnoea, fatigue. Alvesco dosage: 160 Ug, Bid, Inhalation; 160, Bid, Inhalation; 160, Bid, Inhalation. During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ), PROSCAR (View Proscar Review and Proscar Label ), FORADIL (View Foradil Review and Foradil Label ). Patient was hospitalized.

6687657-X | Anaphylactic Reaction, Stomatitis
on Mar 31, 2010 Female patient from GERMANY , 78 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Alvesco (View Usage). Patient had the following side effects: anaphylactic reaction, stomatitis. Alvesco dosage: 200 Ug;1x; Inhalation. During the same period patient was treated with CHLORDIAZEPOXIDE (View Chlordiazepoxide Review and Chlordiazepoxide Label ), ERYTHROMYCIN (View Erythromycin Review and Erythromycin Label ), ESTOLATE (View Estolate Review and Estolate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6687110-3 | Bile Duct Cancer
Patient was taking Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: bile duct cancer on Apr 06, 2010 from GERMANY Additional patient health information: Male patient , 85 years of age, was diagnosed with asthma (What is asthma?), chronic obstructive pulmonary disease and. Alvesco dosage: 400 Ug;bid;inhalation. During the same period patient was treated with THEO DUR (View Theo-dur Review and Theo-dur Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), MUCOSIL 10 (View Mucosil-10 Review and Mucosil-10 Label ), MAINTATE (View Maintate Review and Maintate Label ), RIZE /00624801/ (View Rize /00624801/ Review and Rize /00624801/ Label ), HOCHUUEKKITOU (View Hochuuekkitou Review and Hochuuekkitou Label ), HALCION (View Halcion Review and Halcion Label ).

6652346-4 | Stevens-johnson Syndrome
Adverse event was reported on Mar 11, 2010 by a Female patient taking Alvesco (View Usage) (Dosage: ;bid; Inhalation) was diagnosed with asthma (What is asthma?), rhinitis allergic and. Location: UNITED STATES , 44 years of age, weighting 254.0 lb, Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. During the same period patient was treated with OMNARIS (200 Ug; Qd; Nasal) (View Omnaris Review and Omnaris Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), FEXOFENADINE (View Fexofenadine Review and Fexofenadine Label ), PROAIR HFA (View Proair Hfa Review and Proair Hfa Label ).

6634159-2 | Dyspnoea, Glossodynia, Local Swelling, Oral Candidiasis, Peau D'orange, Swelling Face, Swollen Tongue
on Feb 23, 2010 Female patient from GERMANY , 90 years of age, was diagnosed with lower respiratory tract infection and was treated with Alvesco (View Usage). Patient had the following side effects: dyspnoea, glossodynia, local swelling, oral candidiasis, peau d'orange, swelling face, swollen tongue. Alvesco dosage: 160 Ug;qd;inhalation. During the same period patient was treated with CEFACLOR (View Cefaclor Review and Cefaclor Label ), PULMICORT (View Pulmicort Review and Pulmicort Label ), SEREVENT (View Serevent Review and Serevent Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), LORATADINE (View Loratadine Review and Loratadine Label ), EYE DROPS (View Eye Drops Review and Eye Drops Label ).

6589152-5 | Eczema, Liver Disorder, Pruritus
on Jan 26, 2010 Female patient from JAPAN , 36 years of age, was diagnosed with asthma (What is asthma?), bronchitis (What is bronchitis?) and was treated with Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: eczema (What is eczema?), liver disorder, pruritus. Alvesco dosage: Inhalation. During the same period patient was treated with MUCOSOLVAN L (AMBROXOL HYDROCHLORIDE) (45 Mg; Oral) (View Mucosolvan L (ambroxol Hydrochloride) Review and Mucosolvan L (ambroxol Hydrochloride) Label ), GARENOXACIN (View Garenoxacin Review and Garenoxacin Label ), LANIRAPID (View Lanirapid Review and Lanirapid Label ), CLEANAL (View Cleanal Review and Cleanal Label ), HUSCODE (View Huscode Review and Huscode Label ), UNIPHYL (View Uniphyl Review and Uniphyl Label ), KIPRES (View Kipres Review and Kipres Label ), TAKEPRON (View Takepron Review and Takepron Label ).

6571248-5 | Cataract Operation, Optic Ischaemic Neuropathy
Patient was taking Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: cataract operation, optic ischaemic neuropathy on Jan 14, 2010 from GERMANY Additional patient health information: Male patient , 78 years of age, . Alvesco dosage: 400 Ug; Bid; Inhalation. During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), SPIRIVA (View Spiriva Review and Spiriva Label ).

6554260-1 | Bronchospasm, Dyspnoea
Adverse event was reported on Jan 25, 2010 by a Female patient taking Alvesco (View Usage) (Dosage: One Puff Twice A Day Inhal) was diagnosed with asthma (What is asthma?), cystic fibrosis and. Location: UNITED STATES , child 11 years of age, weighting 85.00 lb, Patient had the following side effects: bronchospasm, dyspnoea. During the same period patient was treated with ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ), COMOLYN SODIUM INHALATION SOLUTION (View Comolyn Sodium Inhalation Solution Review and Comolyn Sodium Inhalation Solution Label ), PULMOZYME (View Pulmozyme Review and Pulmozyme Label ), CREON (View Creon Review and Creon Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), NEXIUM (View Nexium Review and Nexium Label ), SULFAMETH (View Sulfameth Review and Sulfameth Label ).

6551200-6 | Abnormal Dreams, Dysgeusia, Dysphonia, Hallucination, Nightmare, Throat Irritation
on Jan 07, 2010 Female patient from GERMANY , 57 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: abnormal dreams, dysgeusia, dysphonia, hallucination, nightmare, throat irritation. Alvesco dosage: 200 Ug; Bid; Inhalation. During the same period patient was treated with REACTINE /00884301/ (View Reactine /00884301/ Review and Reactine /00884301/ Label ), SINGULAIR (View Singulair Review and Singulair Label ), QUERCETIN (View Quercetin Review and Quercetin Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B12 /00056201/ (View Vitamin B12 /00056201/ Review and Vitamin B12 /00056201/ Label ), VITAMIN A (View Vitamin A Review and Vitamin A Label ), GLUCOSAMINE (View Glucosamine Review and Glucosamine Label ). Patient was hospitalized.

6529631-X | Body Temperature Increased, Haemorrhage Subcutaneous, Rash, Viral Rash
on Dec 17, 2009 Female patient from GERMANY , 35 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature increased, haemorrhage subcutaneous, rash (What is rash?), viral rash. Alvesco dosage: 200 Ug; Qd; Inhalation. Patient was hospitalized.

6467348-0 | Bronchial Secretion Retention, Haemoptysis, Heart Valve Incompetence
Patient was taking Alvesco (View Usage). Patient had the following side effects: bronchial secretion retention, haemoptysis, heart valve incompetence on Nov 12, 2009 from UNITED STATES Additional patient health information: Female patient , 58 years of age, was diagnosed with asthma (What is asthma?) and. Alvesco dosage: 160 Ug;bid;inhalation ; 320 Ug;bid;inhalation. During the same period patient was treated with XOPENEX (View Xopenex Review and Xopenex Label ), XOPENEX HFA INHALATION (View Xopenex Hfa Inhalation Review and Xopenex Hfa Inhalation Label ), AEROSOL (View Aerosol Review and Aerosol Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), NORETHINDRONE AND ETHINYL ESTRADIOL (View Norethindrone And Ethinyl Estradiol Review and Norethindrone And Ethinyl Estradiol Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6455257-2 | Cough, Dyspnoea, Hypertension
Adverse event was reported on Nov 05, 2009 by a Female patient taking Alvesco (View Usage) (Dosage: 320 Ug;qd;inhalation) was diagnosed with asthma (What is asthma?) and. Location: GERMANY , 70 years of age, After Alvesco was administered, patient had the following side effects: cough, dyspnoea, hypertension.

6447338-4 | Dyspnoea, Eye Swelling, Urticaria
on Oct 30, 2009 Male patient from CANADA , 16 years of age, was diagnosed with asthma exercise induced, bronchitis (What is bronchitis?) and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, eye swelling, urticaria. Alvesco dosage: 80 Ug;qd;inhalation.

6442394-1 | Dyspnoea, Glossodynia, Swollen Tongue
on Oct 28, 2009 Female patient from GERMANY , 90 years of age, was treated with Alvesco (View Usage). Patient had the following side effects: dyspnoea, glossodynia, swollen tongue. Alvesco dosage: 160 Ug; Inhalation. During the same period patient was treated with PULMICORT (View Pulmicort Review and Pulmicort Label ), SEREVENT (View Serevent Review and Serevent Label ), PRE MEDS (View Pre Meds Review and Pre Meds Label ).

6431797-7 | Foreign Body
Patient was taking Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: foreign body on Oct 22, 2009 from GERMANY Additional patient health information: Female patient , 61 years of age, was diagnosed with asthma (What is asthma?) and. Alvesco dosage: 200 Ug; Bid; Inhalation. During the same period patient was treated with CON MEDS (View Con Meds Review and Con Meds Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ).

6431796-5 | Body Temperature Increased, C-reactive Protein Increased, Haemorrhage Subcutaneous, Rash, Rash Erythematous
Adverse event was reported on Oct 20, 2009 by a Female patient taking Alvesco (View Usage) (Dosage: 200 Ug; Qd; Inhalation; 200 Ug; Qd; Inhalation) was diagnosed with asthma (What is asthma?) and. Location: GERMANY , 35 years of age, Patient experienced the following unwanted or unexpected effects: body temperature increased, c-reactive protein increased, haemorrhage subcutaneous, rash (What is rash?), rash erythematous. During the same period patient was treated with CON MEDS (View Con Meds Review and Con Meds Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6423537-2 | Anxiety, Arthralgia, Depression, Disturbance In Attention, Dysuria, Irritability
on Oct 14, 2009 Female patient from GERMANY , child 8 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient had the following side effects: anxiety (What is anxiety?), arthralgia, depression (What is depression?), disturbance in attention, dysuria, irritability. Alvesco dosage: 160 Ug; Qd; Inhalation. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ).

6408660-0 | Asthma, Bronchitis
on Oct 02, 2009 Female patient from GERMANY , 55 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: asthma (What is asthma?), bronchitis (What is bronchitis?). Alvesco dosage: 200 Ug;bid;inhalation. During the same period patient was treated with VENTOLIN (View Ventolin Review and Ventolin Label ), SEREVENT (View Serevent Review and Serevent Label ), UNIPHYL (View Uniphyl Review and Uniphyl Label ). Patient was hospitalized.

6406391-4 |
Patient was taking Alvesco (View Usage). on Oct 05, 2009 from UNITED STATES Additional patient health information: Male patient , 51 years of age, . Alvesco dosage: Inhalation.

6391450-5 | Diverticulum, Escherichia Bacteraemia, Headache, Heart Rate Increased, Hypoxia, Pneumonia
Adverse event was reported on Sep 21, 2009 by a Male patient taking Alvesco (View Usage) (Dosage: 160 Ug; Bid; Inhalation) was diagnosed with chronic obstructive pulmonary disease, wheezing and. Location: UNITED STATES , 60 years of age, weighting 176.4 lb, Patient had the following side effects: diverticulum, escherichia bacteraemia, headache (What is headache?), heart rate increased, hypoxia, pneumonia (What is pneumonia?). During the same period patient was treated with BROVANA (View Brovana Review and Brovana Label ). Patient was hospitalized.

6389752-1 | Acute Respiratory Failure, Anaphylactic Reaction, Atrial Fibrillation, Blood Pressure Increased, Cerebrovascular Accident, Circulatory Collapse, Depression, Diabetes Mellitus, Endotracheal Intubation Complication
on Sep 17, 2009 Female patient from UNITED STATES , 85 years of age, was diagnosed with wheezing and was treated with Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: acute respiratory failure, anaphylactic reaction, atrial fibrillation (What is atrial fibrillation?), blood pressure increased, cerebrovascular accident, circulatory collapse, depression (What is depression?), diabetes mellitus, endotracheal intubation complication. Alvesco dosage: 160 Ug; 1x; Inhalation. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), BETAPACE (View Betapace Review and Betapace Label ), LASIX (View Lasix Review and Lasix Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), CITRICAL /00108001/ (View Citrical /00108001/ Review and Citrical /00108001/ Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ). Patient was hospitalized.

6380619-1 | Dysgeusia, Hallucination, Oropharyngeal Pain, Respiratory Disorder
on Sep 08, 2009 Female patient from GERMANY , 56 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: dysgeusia, hallucination, oropharyngeal pain, respiratory disorder. Alvesco dosage: 200 Ug; Bid; Inhalation, 200 Ug; Qd; Inhalation. During the same period patient was treated with ALBUTEROL (View Albuterol Review and Albuterol Label ).

6369368-3 | Dyspnoea, Fall, Hemiplegia, Resuscitation
Patient was taking Alvesco (View Usage). Patient had the following side effects: dyspnoea, fall (What is fall?), hemiplegia, resuscitation on Sep 03, 2009 from UNITED STATES Additional patient health information: Female patient , 85 years of age, was diagnosed with wheezing and. Alvesco dosage: 160 Ug; 1x; Inhalation. Patient was hospitalized.

6346753-7 | Dysgeusia, Dyspnoea, Hallucination, Oropharyngeal Pain
Adverse event was reported on Aug 20, 2009 by a Female patient taking Alvesco (View Usage) (Dosage: 200 Ug; Bid; Inhalation; 200 Ug; Qd; Inhalation) was diagnosed with asthma (What is asthma?) and. Location: GERMANY , 56 years of age, After Alvesco was administered, patient had the following side effects: dysgeusia, dyspnoea, hallucination, oropharyngeal pain. During the same period patient was treated with SALBUTAMOL (CON.) (View Salbutamol (con.) Review and Salbutamol (con.) Label ).

6335929-0 | Dizziness, Ear Pain, Headache, Unevaluable Event
on Aug 31, 2009 Female patient from UNITED STATES , 64 years of age, weighting 200.0 lb, was diagnosed with sarcoidosis and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), ear pain, headache (What is headache?), unevaluable event. Alvesco dosage: 1 Puff Daily. Patient was hospitalized.

6335882-X | Abdominal Pain, Asthma, Bronchitis, Condition Aggravated, Cough, Pneumonia Mycoplasmal, Vomiting, White Blood Cell Count Increased
on Aug 14, 2009 Male patient from JAPAN , child 6 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), asthma (What is asthma?), bronchitis (What is bronchitis?), condition aggravated, cough, pneumonia mycoplasmal, vomiting, white blood cell count increased. Alvesco dosage: Qd; Inhalation. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MIYA BM (View Miya-bm Review and Miya-bm Label ), MUCOSOLVAN /00546002/ (View Mucosolvan /00546002/ Review and Mucosolvan /00546002/ Label ), TELGIN G (View Telgin-g Review and Telgin-g Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MEPTIN (View Meptin Review and Meptin Label ). Patient was hospitalized.

6285645-9 | Myocardial Infarction
Patient was taking Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: myocardial infarction on Jul 09, 2009 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 220.0 lb, . Alvesco dosage: 160 Ug, Inhalation. During the same period patient was treated with NASONEX (View Nasonex Review and Nasonex Label ), AZELASTINE HCL (View Azelastine Hcl Review and Azelastine Hcl Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), SYMBICORT (View Symbicort Review and Symbicort Label ), ACCOLATE (View Accolate Review and Accolate Label ), MAXAIR (View Maxair Review and Maxair Label ), ATROVENT (View Atrovent Review and Atrovent Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

6278248-3 | Abdominal Pain, Asthma, Condition Aggravated, Pneumonia Mycoplasmal, Vomiting
Adverse event was reported on Jul 03, 2009 by a Male patient taking Alvesco (View Usage) (Dosage: ; Qd; Inhalation) was diagnosed with asthma (What is asthma?) and. Location: GERMANY , child 6 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), asthma (What is asthma?), condition aggravated, pneumonia mycoplasmal, vomiting. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MIYA BM (View Miya-bm Review and Miya-bm Label ), MUCOSOLVAN /00546002/ (View Mucosolvan /00546002/ Review and Mucosolvan /00546002/ Label ), TELGIN G (View Telgin-g Review and Telgin-g Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MEPTIN (View Meptin Review and Meptin Label ). Patient was hospitalized.

6222060-8 | Fluid Retention, Ocular Hyperaemia, Pain In Extremity, Spider Vein, Weight Increased
on Jun 08, 2009 Female patient from UNITED STATES , 61 years of age, weighting 163.0 lb, was treated with Alvesco (View Usage). Patient had the following side effects: fluid retention, ocular hyperaemia, pain in extremity, spider vein, weight increased. Alvesco dosage: .

6207611-1 | Abdominal Pain, Bronchitis, Pneumonia Mycoplasmal, Vomiting
on May 13, 2009 Male patient from GERMANY , child 6 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), bronchitis (What is bronchitis?), pneumonia mycoplasmal, vomiting. Alvesco dosage: ; Qd; Inhalation. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MIYA BM (View Miya-bm Review and Miya-bm Label ), MUCOSOLVAN /00546002/ (View Mucosolvan /00546002/ Review and Mucosolvan /00546002/ Label ), TELGIN G (View Telgin-g Review and Telgin-g Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MEPTIN (View Meptin Review and Meptin Label ). Patient was hospitalized.

6199321-4 | Cognitive Disorder, Confusional State, Dizziness, Dysphasia, Irritability, Memory Impairment
Patient was taking Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: cognitive disorder, confusional state, dizziness (What is dizziness?), dysphasia, irritability, memory impairment on May 19, 2009 from UNITED STATES Additional patient health information: Female patient , 44 years of age, weighting 139.0 lb, was diagnosed with asthma (What is asthma?) and. Alvesco dosage: 80mcg 2x Day Inhal. During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), FLECTOR (View Flector Review and Flector Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), CYCLOBENZAPRINE (View Cyclobenzaprine Review and Cyclobenzaprine Label ), B COMPLEX VITAMINS (View B Complex Vitamins Review and B Complex Vitamins Label ), COQ10 (View Coq10 Review and Coq10 Label ), BROMELAIN (View Bromelain Review and Bromelain Label ).

6193517-3 | Dysarthria, Headache, Lethargy, Vomiting
Adverse event was reported on Apr 29, 2009 by a Female patient taking Alvesco (View Usage) (Dosage: Inhalation) . Location: GERMANY , 83 years of age, weighting 121.3 lb, Patient had the following side effects: dysarthria, headache (What is headache?), lethargy, vomiting. During the same period patient was treated with AVAPRO (View Avapro Review and Avapro Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), DUCENE (View Ducene Review and Ducene Label ), IRCAL (View Ircal Review and Ircal Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ALDACTONE (View Aldactone Review and Aldactone Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), FERROGRAD C (View Ferrograd C Review and Ferrograd C Label ).

6183225-7 | Abdominal Pain, Bronchitis, Infantile Asthma, Pneumonia Mycoplasmal, Vomiting
on Apr 21, 2009 Male patient from GERMANY , child 6 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). After Alvesco was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), bronchitis (What is bronchitis?), infantile asthma, pneumonia mycoplasmal, vomiting. Alvesco dosage: Qd; Inhalation. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MIYA BM (View Miya-bm Review and Miya-bm Label ), MUCOSOLVAN /00546002/ (View Mucosolvan /00546002/ Review and Mucosolvan /00546002/ Label ), TELGIN G (View Telgin-g Review and Telgin-g Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), MEPTIN (View Meptin Review and Meptin Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ). Patient was hospitalized.

6148953-8 | Angioedema, Dry Mouth, Pharyngeal Erythema, Pruritus, Rash
on Mar 20, 2009 Female patient from GERMANY , 59 years of age, was diagnosed with asthma (What is asthma?) and was treated with Alvesco (View Usage). Patient experienced the following unwanted or unexpected effects: angioedema, dry mouth, pharyngeal erythema, pruritus, rash (What is rash?). Alvesco dosage: 160 Ug; Qd; Inhalation. During the same period patient was treated with ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PREV MEDS (View Prev Meds Review and Prev Meds Label ).

6140342-5 | Angioedema, Dry Mouth, Pharyngeal Erythema, Pruritus, Rash
Patient was taking Alvesco (View Usage). Patient had the following side effects: angioedema, dry mouth, pharyngeal erythema, pruritus, rash (What is rash?) on Mar 13, 2009 from GERMANY Additional patient health information: Female patient , 59 years of age, was diagnosed with asthma (What is asthma?) and. Alvesco dosage: 160 Ug; Qd; Inhalation.